Physical activity programmes such as the NSC can help mitigate rising obesity and T2DM prevalence when implemented at the population level, as seen in Singapore. However, their success depends on ...
We present one of the first comprehensive evaluations of predictive information derived from retinal fundus photographs, illustrating the potential and limitations of readily accessible and low-cost ...
Each year, millions of individuals are admitted to intensive care units (ICUs) worldwide; for every patient treated in the ICU, there is often at least one other unseen vulnerable individual—the ...
Venous thromboembolism includes deep vein thrombosis (DVT) and pulmonary embolism, which have incidence rates of between 1 and 2 cases per 1000 people for the first episode.1,2 Strong, provoking risk ...
As the global population ages, older adults with atherosclerotic cardiovascular disease (ASCVD) are projected to drive a ...
Men and partners are important contributors to the health of future generations, yet their own preconception health and wellbeing remain secondary considerations in research, practice, and policy.
Chronic hepatitis D coinfection affects an estimated 12 million people globally, with higher prevalence in low-income and middle-income countries, especially the African and Western Pacific regions.
Africa carries a disproportionate share of the global hepatitis B virus (HBV) burden.1 An estimated 64·7 million people in Africa are living with chronic HBV infection—a condition associated with high ...
There was some evidence that cannabinoids can reduce symptoms of cannabis use disorder, insomnia, tic or Tourette's syndrome, and autism spectrum disorder, but the quality of this evidence was ...
Vertical health delivery programmes were highly effective in rapid roll-out of HIV services in high-burden countries in ...
In this large international cohort of immunocompromised patients with ARF, we identified key risk and protective factors for mortality and intubation. These findings could improve outcomes by ...
The care of immunocompromised adults with acute respiratory failure (ARF) remains one of the greatest challenges of intensive care medicine.1 Management of these patients is challenging because ...